arxiv
PublishedOctober 19, 2026 at 4:00 AM
Generative molecule evolution using 3D pharmacophore for efficient Structure-Based Drug Design
Publisher summary· verbatim
arXiv:2507.20130v2 Announce Type: replace Abstract: Recent breakthroughs in generative models have shown great promise for drug discovery, yet Structure-Based Drug Design (SBDD) faces two critical challenges: the scarcity of high-quality protein-ligand complex data and the practical synthesizability
Stay posted· Newsletter
Three short emails a week: Monday, Wednesday and Friday. Top movers, new models and the most-referenced story.
Your email is used only to send The Bubble Brief. Privacy policy
Discussion
No replies yet. Be first.
Related coverage
More from ARXIV
arxivAn AI Security Agent for University ACMIS: Multi-Vector Threat Detection and Automated Response9harxivLearning Transferable Latent User Preferences for Human-Aligned Decision Making9harxivRepair the Core, Not the Symptom: Planning-Graph Repair for Long-Horizon Agents9harxivIndustryForge-27B: A Domain-Enhanced Multimodal Foundation Model for Industrial CAD9hThe Bubble Brief
MON · WED · FRIRead AI insights every Monday, Wednesday and Friday — top movers, new models, story of the week.
Your email is used only to send The Bubble Brief. Privacy policy
Originally published on arxiv ↗